Delivery Order SPE2DB20D3101-SPE2DB24FRMC6
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,135.44 contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of November 23, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,946.53 firm fixed-price contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $11,831.94 firm fixed-price contract is for the delivery of Trelegy Ellipta 100-62.5-25 medication, a combination drug product used to treat chronic obstructive pulmonary disease (COPD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The $7,777.37 contract has a firm fixed price and an ultimate completion date of December 2, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,136.67 firm fixed-price contract is for the supply of Trelegy Ellipta, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of January 2, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,101.59, is for the supply of Trelegy Ellipta 200-62.5-25 60s, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The order has an ultimate completion date of February 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,336.61 firm fixed-price contract is for the provision of Trelegy Ellipta 100-62.5-25 60S, a prescription medication. This order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $63,512.59 firm fixed-price contract covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of September 27, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,204.87 firm fixed price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 28, 2023 and was awarded on March 27, 2023. This delivery order is part of a larger $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,497.75 firm fixed-price contract is for the supply of Trelegy Ellipta 200-62.5-25 60s medication. The contract has an ultimate completion date of July 10, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRMC6Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,720.75 firm fixed-price contract is for the supply of Trelegy Ellipta 100-62.5-25 medication, which is a combination drug used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of June 7, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 6/6/24 |